Hu Y, Li H, Wang K, Wu D, et al. Single- and multiple-dose pharmacokinetics and safety of the SARS-CoV-2 3CL protease inhibitor RAY1216: a phase 1 study in healthy participants. Antimicrob Agents Chemother 2025 Jan 31:e0145024. doi: 10.1128/aac.01450.
PMID: 39887246